Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease

Gut

Volumn 51, Issue 4, 2002, Pages 472-474

  Galmiche, J P ^a   Zerbib, F ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

AGING; CANCER RISK; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LONG TERM CARE; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; STOMACH FUNDOPLICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; LONG-TERM CARE; POSTOPERATIVE COMPLICATIONS; PROTON PUMPS; STOMACH NEOPLASMS;

EID: 0036785344     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.4.472     Document Type: Short Survey

References (26)

1. Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 1992;326:786-92.
2. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001;285:2331-8.
3. Lundell L, Miettinen P, Myrvold HE, et al. Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study Group. Eur J Gastroenterol Hepatol 2000;12:879-87.
4. Lundell L, Miettinen P, Myrvold HE, et al. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 2001;192:172-9.
5. Slim K, Bousquet J, Kwiatkowski F, et al. Quality of life before and after laparoscopic fundoplication. Am J Surg 2000;180:41-5.
6. Fibbe C, Layer P, Keller J, et al. Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology 2001;121:5-14.
7. Luostorinen M, Isolauri J, Laitinen J, et al. Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis. Gut 1993;34:1015-20.
8. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997;11:765-73.
9. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998;10:119-24.
10. Kahrilas PJ. Management of GERD: medical versus surgical. Semin Gastrointest Dis 2001;12:3-15.
11. So JB, Zeitels SM, Rattner DW. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998;124:28-32.
12. Kamel PL, Hanson D, Kahrilas PJ. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994;96:321-6.
13. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996;100:395-405.
14. Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997;42:2138-45.
15. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42-9.
16. Tibbling L, Gibellino F. Remission of angina pectoris and dyspnea by fundoplication in gastro-oesophageal reflux disease. Ann Med 1992;24:457-9.
17. Armstrong D. Long-term safely and efficacy of omeprazole in gastro-oesophageal reflux disease. Lancet 2000;356:610-12.
18. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000;118:661-9.
19. Bais JE, Bartelsman JF, Bonjer HJ, et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet 2000;355:170-4.
20. Soot SJ, Eshraghi N, Farahmand M, et al. Transition from open to laparoscopic fundoplication: the learning curve. Arch Surg 1999;134:278-81.
21. Vakil N, Treml S, Shaw M, et al. The outcome of laparoscopic fundoplication for reflux disease in community practice in the USA. Gastroenterology 2001;120:A16.
22. O'Connor HJ, O'Morain CA. Helicobacter pylori and gastroesophageal reflux disease: to treat or not to treat? Scand J Gastroenterol 2001;36:677-82.
23. Viljakka M, Nevalainen J, Isolauri J. Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastroenterol 1997;32:766-72.
24. Heudebert GR, Marks R, Wilcox CM, et al. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology 1997;112:1078-86.
25. Myrvold HE, Lundell L, Miettinen P, et al. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut 2001;49:488-94.
26. Galmiche JP, Barouk J. Endoscopic treatment of gastroesophageal reflux disease: fact or fancy? Curr Gastroenterol Rep 2002;4:177-8.